Stocks › ALLK
ALLK
ALLK·USD
—
No end-of-day price on record
ALLK
ALLK
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
ALLKS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of ALLK by members of U.S. Congress · 1 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Christopher L. JacobsHouse · R · NY |
ALLKALLK · Stock |
Purchase $1,001 - $15,000 |
Jul 28, 2022 | Jun 16, 2022 | Filing ↗ |
Whale Activity
Position changes in ALLK reported for 2025-06-30 by 61 institutional filers
- Increased0
- New0
- Held0
- Decreased0
- Closed61
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| Alta Partners Management Company, L.P. | 0 | $0 | closed |
| Federation des caisses Desjardins du Quebec | 0 | $0 | closed |
| BlackRock, Inc. | 0 | $0 | closed |
| Deuterium Capital Management, LLC | 0 | $0 | closed |
| Deep Track Capital, LP | 0 | $0 | closed |
| SBI Securities Co., Ltd. | 0 | $0 | closed |
| CERTUITY, LLC | 0 | $0 | closed |
| Comprehensive Financial Management LLC | 0 | $0 | closed |
| Logos Global Management LP | 0 | $0 | closed |
| Ikarian Capital, LLC | 0 | $0 | closed |
| Affinity Asset Advisors, LLC | 0 | $0 | closed |
| SAMSARA BIOCAPITAL, LLC | 0 | $0 | closed |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by ALLK insiders, by quarter · Form 4
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
322 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND II LP | Disposition to issuer | −855.2K | — | — | May 15, 2025 | Form 4 ↗ |
| BIOTECHNOLOGY VALUE FUND II LP | Disposition to issuer | −6.8M | — | — | May 15, 2025 | Form 4 ↗ |
| BIOTECHNOLOGY VALUE FUND II LP | Disposition to issuer | −8.7M | — | — | May 15, 2025 | Form 4 ↗ |
| Tomasi AdamPresident | Disposition to issuer | −20.8K | — | — | May 15, 2025 | Form 4 ↗ |
| Tomasi AdamPresident | Disposition to issuer | −512.6K | — | — | May 15, 2025 | Form 4 ↗ |
| Radford Harlan BairdChief Financial Officer | Disposition to issuer | −163.4K | — | — | May 15, 2025 | Form 4 ↗ |
| Alexander RobertChief Executive Officer · Director | Disposition to issuer | −320.3K | — | — | May 15, 2025 | Form 4 ↗ |
| Alexander RobertChief Executive Officer · Director | Disposition to issuer | −738.1K | — | — | May 15, 2025 | Form 4 ↗ |
| Walker Paul EdwardDirector | Disposition to issuer | −3.4M | — | — | May 15, 2025 | Form 4 ↗ |
| Walker Paul EdwardDirector | Disposition to issuer | −2.8M | — | — | May 15, 2025 | Form 4 ↗ |
| Alexander RobertChief Executive Officer · Director | Tax withholding | −31.4K | $0.26 | $8K | Mar 6, 2025 | Form 4 ↗ |
| Tomasi AdamPresident | Tax withholding | −20.0K | $0.26 | $5K | Mar 5, 2025 | Form 4 ↗ |
| Radford Harlan BairdChief Financial Officer | Tax withholding | −14.2K | $0.26 | $4K | Mar 5, 2025 | Form 4 ↗ |
| Tomasi AdamPresident | Tax withholding | −21.1K | $1.10 | $23K | Dec 6, 2024 | Form 4 ↗ |
| Radford Harlan BairdChief Financial Officer | Tax withholding | −13.1K | $1.10 | $14K | Dec 6, 2024 | Form 4 ↗ |
| Alexander RobertChief Executive Officer · Director | Tax withholding | −32.5K | $1.10 | $36K | Dec 5, 2024 | Form 4 ↗ |
| Lee Chin HyokChief Medical Officer | Tax withholding | −10.6K | $1.13 | $12K | Dec 4, 2024 | Form 4 ↗ |
| Alexander RobertChief Executive Officer · Director | Tax withholding | −37.3K | $0.58 | $22K | Sep 11, 2024 | Form 4 ↗ |
| Lee Chin HyokChief Medical Officer | Tax withholding | −45.3K | $0.65 | $29K | Sep 9, 2024 | Form 4 ↗ |
| Tomasi AdamPresident | Tax withholding | −22.0K | $0.65 | $14K | Sep 6, 2024 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding ALLK · SEC Form N-PORT
No mutual fund or ETF has reported ALLK in an N-PORT filing in the last seven months.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming ALLK as client
No lobbying filings found naming ALLK as the client.
Government Contracts
Federal awards to ALLK · USAspending
No federal contract awards found for ALLK.
U.S. Patents
Recent USPTO applications naming ALLK
No USPTO patent applications found for ALLK.
Annual Financials
From ALLK's 10-K filings · XBRL
ALLK is not in SEC's company list, so there are no XBRL filings to show.
Stock Splits
Every split and reverse split in the price history
No price history on record for ALLK.
Material Events (8-K)
Corporate events filed with the SEC
No 8-K filings on record.
About ALLK
From SEC EDGAR company records
No company profile on record.

